论文部分内容阅读
目的:分析和研究分别采用地屈孕酮和黄体酮对先兆流产患者进行临床治疗的情况及效果。方法:随机抽取2014年10月~2015年03月期间,在我院妇产科进行治疗的先兆流产患者46例。按照抽签法对他们进行随机平均分组,其中对照组23例,采用黄体酮进行临床治疗;观察组23例,采用黄体酮联合地屈孕酮进行临床治疗,并对比、统计和分析两组患者的临床诊治效果。结果:经过临床对比分析显示,观察组患者的临床治疗总有效率(95.65%)略高于对照组患者(73.91%),组间比较的差异性明显,具有统计学意义(P<0.05)。不良反应率(4.35%)略低于对照组患者(8.70%),但组间比较的差异性不大,不具有统计学意义(P>0.05)。结论:采用黄体酮联合地屈孕酮对先兆流产患者进行临床诊治的效果更佳,不良反应率更低,因此,它是一种有效、安全、理想的临床治疗。
OBJECTIVE: To analyze and study the clinical effect of gemcitabine and progesterone on the clinical treatment of threatened abortion. Methods: A total of 46 patients with threatened abortion underwent gynecology and obstetrics in our hospital from October 2014 to March 2015. According to the random sampling method, they were randomly divided into groups, of which 23 cases of control group, the clinical treatment with progesterone; observation group of 23 cases, the use of progesterone progesterone in combination with progesterone clinical treatment, and statistics, and analysis of two groups of patients Clinical diagnosis and treatment effect. Results: After clinical contrast analysis, the total effective rate of clinical observation in the observation group was slightly higher than that of the control group (95.65%) (73.91%). The differences between the two groups were significant and statistically significant (P <0.05). Adverse reaction rate (4.35%) was slightly lower than that of the control group (8.70%), but there was no significant difference between the two groups (P> 0.05). Conclusion: Progesterone combined with dydrogesterone is more effective, safe and ideal for the clinical diagnosis and treatment of threatened abortion.